| Dr Roy Alan Shih Hsien Goo, PHARMD | |
|
98-1079 Moanalua Rd, Aiea, HI 96701-4713 | |
| (808) 485-4230 | |
| Not Available |
| Full Name | Dr Roy Alan Shih Hsien Goo |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 98-1079 Moanalua Rd, Aiea, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265732630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH-2669 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roy Alan Shih Hsien Goo, PHARMD 652 Aipo St, Honolulu, HI 96825-2433 Ph: () - | Dr Roy Alan Shih Hsien Goo, PHARMD 98-1079 Moanalua Rd, Aiea, HI 96701-4713 Ph: (808) 485-4230 |
News Archive
A new study published today in the journal Cell Reports by scientists at the German Cancer Research Center (DKFZ) shows that the direction taken by a cancer cell depends on the configuration of the cell itself as well as the activation of a universal cancer cell receptor called CD95.
Talecris Biotherapeutics Holdings Inc. announced today that a jury in the General Court of Justice, Superior Court Division, Wake County, North Carolina, rendered a verdict on December 13, 2010 in the amount of $37 million in favor of Plasma Centers of America, LLC, against its subsidiary, Talecris Plasma Resources, Inc., in a breach of contract claim.
Fecal microbiota transplantation or stool transplant from a donor is useful for patients infected with the deadly recurrent Clostridium difficile that leads to severe diarrhea, pain and often serious consequences.
New computer models that show how microtubules age are the first to match experimental results and help explain the dynamic processes behind an essential component of every living cell, according to Rice University scientists.
Abraxis BioScience, Inc., a fully integrated biotechnology company, welcomes the announcement today that following a full submission, the Scottish Medicines Consortium (SMC) has accepted ABRAXANE® (paclitaxel albumin) for restricted use within the National Health Service (NHS) for Scotland in patients who would otherwise receive docetaxel or 3-weekly solvent-based paclitaxel as second-line treatment for metastatic breast cancer.
› Verified 9 days ago
Sung Mi Yoon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 400, Aiea, HI 96701 Phone: 808-488-0958 | |
Kent Hirata, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 400, Aiea, HI 96701 Phone: 808-488-0958 Fax: 808-484-0857 | |
Kailey Hifumi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr Ste 103, Aiea, HI 96701 Phone: 088-408-5681 | |
Christopher Masatoshi Okawa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98-719 Iho Pl Apt 401, Aiea, HI 96701 Phone: 808-488-0681 Fax: 808-488-6043 | |
Laurie Yonamine, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 99-115 Aiea Heights Dr, Aiea, HI 96701 Phone: 808-483-3071 | |
Mrs. Rachael Nakamura, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98-1005 Moanalua Rd Spc 400, Aiea, HI 96701 Phone: 808-488-0958 | |
Patrice Baba, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 98-1247 Kaahumanu St Ste 220, Aiea, HI 96701 Phone: 808-468-4655 Fax: 808-468-4755 |